Financials

Note: The above unaudited pro forma condensed consolidated statement of operations exclude the effects of the following:

For all periods presented:

• Acquired in-process research and development, amortization of purchased product rights, goodwill and other purchased intangibles.
• Provision for income taxes adjusted to an effective tax rate of zero on losses and 30% on income.

For the three and nine months ended September 30, 2001:

• Net gain on disposition of strategic long-term investment ($1.4M).
• Write-down of strategic long-term investments ($1.7M) and ($7.8M) for the three and nine months ended September 30, 2001, respectively.

For the nine months ended September 30, 2001:

• Impairment of purchased products rights, goodwill and other purchased intangibles ($327.0M).
• Restructuring charges including: expenses associated with the workforce reduction ($13.5M), closure of facilities ($38.2M), and expenses related to the discontinuance of non-core products and programs ($13.8M).
• Special non-recurring charges including: workforce related expenses for Restructuring related employee relocations, CEO bonus and hiring fees ($4.1M), write-down of fixed assets and leasehold improvements related to facilities closures ($13.5M), expenses related to the write-off accounts receivable and increase in the allowance for doubtful accounts ($11.0M), and expenses and impairment of assets related to rebranding and expenses related to the discontinuance of non-core products and programs ($6.7M).